The burgeoning interest in GLP-3 agonists for glucose control has sparked considerable investigation into their mechanisms of action, particularly concerning their potential interaction with the RET pathway. While https://harleyckql638660.losblogos.com/37690969/glp-3-therapies-and-ret-signaling-a-comparative-analysis